RESEARCH_money benefit tools

Patients with advanced non-small cell lung cancer (NSCLC) who receive treatment live longer than those who remain untreated, but the proportion of NSCLC patients with advanced disease who don’t receive treatment has been rising in the United States.

Read the article: https://lungcancernewstoday.com/2017/01/26/advanced-nsclc-patients-live-longer-when-treated-but-proportion-untreated-patients-rising/